Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates

Transfusion Medicine

Volumn 15, Issue 4, 2005, Pages 269-276

  Pinna, D ^a   Sampson Johannes, A ^c   Clementi, M ^a,b   Poli, G ^a,b   Rossini, S ^a   Lin, L ^c   Vicenzi, Elisa ^a,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c CERUS CORPORATION   (United States)

^d P2 P3 Laboratories   (Italy)

Author keywords

Amotosalen photochemical inactivation; Platelet concentrates; SARS coronavirus

Indexed keywords

AMOTOSALEN; PSORALEN; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG; PHOTOSENSITIZING AGENT; PSORALEN DERIVATIVE; S 59, PSORALEN; S-59, PSORALEN;

ANIMAL CELL; APHERESIS; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DEVICE; HUMAN; INOCULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTOCHEMOTHERAPY; PLAQUE FORMING CELL; SARS CORONAVIRUS; ULTRAVIOLET A RADIATION; VIRUS INACTIVATION; VIRUS INFECTIVITY; BLOOD STORAGE; DRUG EFFECT; INSTRUMENT STERILIZATION; METHODOLOGY; PHOTOLYSIS; RADIATION EXPOSURE; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; VIROLOGY;

BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; PHOTOLYSIS; PHOTOSENSITIZING AGENTS; PLATELET TRANSFUSION; PLATELETPHERESIS; PSORALENS; SARS VIRUS; STERILIZATION; VIRUS INACTIVATION;

EID: 27744573745     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.0958-7578.2005.00588.x     Document Type: Article

References (45)

1. Allain, J.P. (2004) Occult hepatitis B virus infection: implications in transfusion. Vox Sanguinis, 86, 83-91.
2. Busch, M.P., Kleinman, S.H., Jackson, B., Stramer, S.L., Hewlett, I. & Preston, S. (2000) Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion, 40, 143-159.
3. Chen, W., Xu, Z., Mu, J., Yang, L., Gan, H., Mu, F., Fan, B., He, B., Huang, S., You, B., Yang, Y., Tang, X., Qiu, L., Qiu, Y., Wen, J., Fang, J. & Wang, J. (2004) Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection. Journal of Medical Microbiology, 53, 435-438.
4. Cheng, P.K., Wong, D.A., Tong, L.K., Ip, S.M., Lo, A.C., Lau, C.S., Yeung, E.Y. & Lim, W.W. (2004) Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet, 363, 1699-1700.
5. Dodd, R.Y., Notari IV, E.P. & Stramer, S.L. (2002) Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion, 42, 975-979.
6. Drosten, C., Chiu, L.L., Panning, M., Leong, H.N., Preiser, W., Tam, J.S., Gunther, S., Kramme, S., Emmerich, P., Ng, W.L., Schmitz, H. & Koay, E.S. (2004) Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. Journal of Clinical Microbiology, 42, 2043-2047.
7. Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H.R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R.A., Berger, A., Burguiere, A.M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.C., Muller, S., Rickerts, V., Sturmer, M., Vieth, S., Klenk, H.D., Osterhaus, A.D., Schmitz, H. & Doerr, H.W. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. The New England Journal of Medicine, 348, 1967-1976.
8. Goodnough, L.T., Brecher, M.E., Kanter, M.H. & AuBuchon, J.P. (1999) Transfusion medicine: blood transfusion. The New England Journal of Medicine, 340, 438-447.
9. Grant, P.R., Garson, J.A., Tedder, R.S., Chan, P.K., Tam, J.S. & Sung, J.J. (2003) Detection of SARS coronavirus in plasma by real-time RT-PCR. The New England Journal of Medicine, 349, 2468-2469.
10. Grass, J.A., Hei, D.J., Metchette, K., Cimino, G.D., Wiesehahn, G.P., Corash, L. & Lin, L. (1998) Inactivation of leukocytes in platelet concentrates by psoralen plus UVA. Blood, 91, 2180-2188.
11. Guan, Y., Zheng, B.J., He, Y.Q., Liu, X.L., Zhuang, Z.X., Cheung, C.L., Luo, S.W., Li, P.H., Zhang, L.J., Guan, Y.J., Butt, K.M., Wong, K.L., Chan, K.W., Lim, W., Shortridge, K.F., Yuen, K.Y., Peiris, J.S. & Poon, L.L. (2003) Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science, 302, 276-278.
12. Harrington, T., Kuehnert, M.J., Kamel, H., Lanciotti, R.S., Hand, S., Currier, M., Chamberland, M.E., Petersen, L.R. & Marfin, A.A. (2003) West Nile virus infection transmitted by blood transfusion. Transfusion, 43, 1018-1022.
13. Holmes, K.V. (2003) SARS coronavirus: a new challenge for prevention and therapy. The Journal of Clinical Investigation, 111, 1605-1609.
14. Ksiazek, T.G., Erdman, D., Goldsmith, C.S., Zaki, S.R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J.A., Lim, W., Rollin, P.E., Dowell, S.F., Ling, A.E., Humphrey, C.D., Shieh, W.J., Guarner, J., Paddock, C.D., Rota, P., Fields, B., DeRisi, J., Yang, J.Y., Cox, N., Hughes, J.M., LeDuc, J.W., Bellini, W.J., Anderson, L.J. & Group, S.W. (2003) A novel coronavirus associated with severe acute respiratory syndrome. The New England Journal of Medicine, 348, 1953-1966.
15. Lau, L.T., Fung, Y.W., Wong, F.P., Lin, S.S., Wang, C.R., Li, H.L., Dillon, N., Collins, R.A., Tam, J.S., Chan, P.K., Wang, C.G. & Yu A.C. (2003) A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification. Biochemical and Biophysical Research Communications, 312, 1290-1296.
16. Lin, L., Alfonso, R., Behrman, B., Corten, L., Damonte, P.B., Dikeman, R., Dupuis, K., Hei, D., Lin, C.Y., Londe, H.F., Metchette, K., Phan, T., Reames, A.A., Rheinschmidt, M., Savoor, A., Tessman, J. & Corash, L. (1998) Photochemical treatment of platelet concentrates with a novel psoralen and UVA to enhance the safety of platelet transfusions. Infusion Therapy and Transfusion Medicine, 25, 39-48.
17. Lin, L., Cook, D.N., Wiesehahn, G.P., Alfonso, R., Behrman, B., Cimino, G.D., Corten, L., Damonte, P.B., Dikeman, R., Dupuis, K., Fang, Y.M., Hanson, C.V., Hearst, J.E., Lin, C.Y., Londe, H.F., Metchette, K., Nerio, A.T., Pu, J.T., Reames, A.A., Rheinschmidt, M., Tessman, J., Isaacs, S.T., Wollowitz, S. & Corash, L. (1997) Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion, 37, 423-435.
18. Lin, L., Dikeman, R., Molini, B., Lukehart, S.A., Lane, R., Dupuis, K., Metzel, P. & Corash, L. (2004) Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion, 44, 1496-1504.
19. Lipsitch, M., Cohen, T., Cooper, B., Robins, J.M., Ma, S., James, L., Gopalakrishna, G., Chew, S.K., Tan, C.C., Samore, M.H., Fisman, D. & Murray, M. (2003) Transmission dynamics and control of severe acute respiratory syndrome. Science, 300, 1966-1970.
20. Mahony, J.B., Petrich, A., Louie, L., Song, X., Chong, S., Smieja, M., Chernesky, M., Loeb, M. & Richardson, S. (2004) Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus. Journal of Clinical Microbiology, 42, 1471-1476.
21. McCullough, J., Vesole, D.H., Benjamin, R.J., Slichter, S.J., Pineda, A., Snyder, E., Stadtmauer, E.A., Lopez-Plaza, I., Coutre, S., Strauss, R.G., Goodnough, L.T., Fridey, J.L., Raife, T., Cable, R., Murphy, S., Howard, F.T., Davis, K., Lin, J.S., Metzel, P., Corash, L., Koutsoukos, A., Lin, L., Buchholz, D.H. & Conlan, M.G. (2004) Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood, 104, 1534-1541.
22. Ng, L.F., Wong, M., Koh, S., Ooi, E.E., Tang, K.F., Leong, H.N., Ling, A.E., Agathe, L.V., Tan, J., Liu, E.T., Ren, E.C., Ng, L.C. & Hibberd, M.L. (2004) Detection of severe acute respiratory syndrome coronavirus in blood of infected patients. Journal of Clinical Microbiology, 42, 347-350.
23. Peiris, J.S., Lai, S.T., Poon, L.L., Guan, Y., Yam, L.Y., Lim, W., Nicholls, J., Yee, W.K., Yan, W.W., Cheung, M.T., Cheng, V.C., Chan, K.H., Tsang, D.N., Yung, R.W., Ng, T.K. & Yuen, K.Y. (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 361, 1319-1325.
24. Phelps, R., Robbins, K., Liberti, T., Machuca, A., Leparc, G., Chamberland, M., Kalish, M., Hewlett, I., Folks, T., Lee, L.M. & McKenna, M. (2004) Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion, 44, 929-933.
25. Poon, L.L., Wong, B.W., Chan, K.H., Leung, C.S., Yuen, K.Y., Guan, Y. & Peiris, J.S. (2004) A one step quantitative RT-PCR for detection of SARS coronavirus with an internal control for PCR inhibitors. Journal of Clinical Virology, 30, 214-217.
26. van Rhenen, D., Gulliksson, H., Cazenave, J.P., Pamphilon, D., Ljungman, P., Kluter, H., Vermeij, H., Kappers-Klunne, M., de Greef, G., Laforet, M., Lioure, B., Davis, K., Marblie, S., Mayaudon, V., Flament, J., Conlan, M., Lin, L., Metzel, P., Buchholz, D. & Corash, L. (2003) Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood, 101, 2426-2433.
27. Rota, P.A., Oberste, M.S., Monroe, S.S., Nix, W.A., Campagnoli, R., Icenogle, J.P., Penaranda, S., Bankamp, B., Maher, K., Chen, M.H., Tong, S., Tamin, A., Lowe, L., Frace, M., DeRisi, J.L., Chen, Q., Wang, D., Erdman, D.D., Peret, T.C., Burns, C., Ksiazek, T.G., Rollin, P.E., Sanchez, A., Liffick, S., Holloway, B., Limor, J., McCaustland, K., Olsen-Rasmussen, M., Fouchier, R., Gunther, S., Osterhaus, A.D., Drosten, C., Pallansch, M.A., Anderson, L.J. & Bellini, W.J. (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 300, 1394-1399.
28. Ruan, Y.J., Wei, C.L., Ee, A.L., Vega, V.B., Thoreau, H., Su, S.T., Chia, J.M., Ng, P., Chiu, K.P., Lim, L., Zhang, T., Peng, C.K., Lin, E.O., Lee, N.M., Yee, S.L., Ng, L.F., Chee, R.E., Stanton, L.W., Long, P.M. & Liu, E.T. (2003) Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet, 361, 1779-1785.
29. Schmidt, M., Brixner, V., Ruster, B., Hourfar, M.K., Drosten, C., Preiser, W., Seifried, E. & Roth, W.K. (2004) NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion, 44, 470-475.
30. Theron, M. (2004) Prevalence of non-pneumonic infections with SARS-correlated virus. Lancet, 363, 1826-1827.
31. Tong, T.R. & Liang, C. (2004) Evidence of airborne transmission of SARS. The New England Journal of Medicine, 351, 609-611.
32. VanVoorhis, W.C., Barrett, L.K., Eastman, R.T., Alfonso, R. & Dupuis, K. (2003) Trypanosoma cruzi inactivation in human platelet concentrates and plasma by psoralen (amotosalen HCl) and long-wavelength UV. Antimicrobial Agents and Chemotherapy, 47, 475-479.
33. Vega, V.B., Ruan, Y., Liu, J., Lee, W.H., Wei, C.L., Se-Thoe, S.Y., Tang, K.F., Zhang, T., Kolatkar, P.R., Ooi, E.E., Ling, A.E., Stanton, L.W., Long, P.M. & Liu, E.T. (2004) Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003. BMC Infectious Diseases, 4, 32.
34. Vicenzi, E., Canducci, F., Pinna, D., Mancini, N., Carletti, S., Lazzarin, A., Bordignon, C., Poli, G. & Clementi, M. (2004) Coronaviridae and SARS-associated coronavirus strain HSR1. Emerging Infectious Diseases, 10, 413-418.
35. Wollowitz, S. (2001) Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Seminars in Hematology, 38, 4-11.
36. Woo, P.C., Lau, S.K., Tsoi, H.W., Chan, K.H., Wong, B.H., Che, X.Y., Tam, V.K., Tam, S.C., Cheng, V.C., Hung, I.F., Wong, S.S., Zheng, B.J., Guan, Y. & Yuen, K.Y. (2004) Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet, 363, 841-845.
37. World Health Organization (2003) Summary of Probable SARS Cases with Onset of Illness from 1 November 2002-26 September 2003 (monograph on the Internet). Available from http://www.who.int/csr/sars/country/table2003_09_23/en (cited 26 September 2003).
38. Wu, J., Xu, F., Zhou, W., Feikin, D.R., Lin, C.Y., He, X., Zhu, Z., Liang, W., Chin, D.P. & Schuchat, A. (2004) Risk factors for SARS among persons without known contact with SARS patients, Beijing. China. Emerging Infectious Diseases, 10, 210-216.
39. Yam, W.C., Chan, K.H., Poon, L.L., Guan, Y., Yuen, K.Y., Seto, W.H. & Peiris, J.S. (2003) Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. Journal of Clinical Microbiology, 41, 4521-4524.
40. Yeh, S.H., Wang, H.Y., Tsai, C.Y., Kao, C.L., Yang, J.Y., Liu, H.W., Su, I.J., Tsai, S.F., Chen, D.S. & Chen, P.J. (2004) Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proceedings of the National Academy of Sciences USA, 101, 2542-2547.
41. Yip, C.W., Hon, C.C., Zeng, F., Chow, K.Y. & Leung, F.C. (2004) Prevalence of non-pneumonic infections with SARS-correlated virus. Lancet, 363, 1826-1827.
42. Young, M. (2004) Prevalence of non-pneumonic infections with SARS-correlated virus. Lancet, 363, 1826-1827.
43. Yu, A.C. (2004) The difficulties of testing for SARS. Science, 303, 469-471.
44. Yu, A.C., Lau, L.T. & Fung, Y.W. (2004) Boosting the sensitivity of real-time polymerase-chain-reaction testing for SARS. The New England Journal of Medicine, 350, 1577-1579.
45. Zhou, Y.H. (2004) Prevalence of non-pneumonic infections with SARS-correlated virus. Lancet, 363, 1826-1827.